Today news
Donald Trump
Donald John Trump (born June 14, 1946) is the 45th and current president of the United States. Before entering politics, he was a businessman and television personality.
Trump was born and raised in Queens, a borough of New York City, and received a bachelor's degree in economics from the Wharton School. He took charge of his family's real-estate business in 1971, renamed it The Trump Organization, and expanded its operations from Queens and Brooklyn into Manhattan. The company built or renovated skyscrapers, hotels, casinos, and golf courses. Trump later started various side ventures, mostly by licensing his name. He bought the Miss Universe brand of beauty pageants in 1996, and sold it in 2015. He produced and hosted The Apprentice, a reality television series, from 2003 to 2015. As of 2020, Forbes estimated his net worth to be $2.1 billion.[
The same in other media
Rihanna unveils men’s harness as part of new Fenty lingerie collection
Reading now: 125
Madonna’s eldest daughter, Lourdes Leon). However, others have also commented on the designs themselves – including those for men.The collection includes a ‘Glossy Flossy Harness’ for men in ‘Goji Berry Red’.
There’s also ‘Glossy Flossy Crop Top’, and Mesh Briefs, along with heart-adorned satin boxers.Online, the designs prompted plenty of comments.OH RIHANNA.
The website meaws.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
19.02 / 15:55
hiv
Treating HIV is about to get a whole lot easier
Related: FDA approves first long-acting HIV medication: a monthly injectionThe once-every-two-month injection is for HIV-positive adults who are already virally suppressed, have shown no previous treatment failure or resistance to either of the drugs involved.The FDA granted approval after results from a trial showed the injections remained efficient if given every couple of months.The lead researcher involved with that trial, Turner Overton, MD, a professor of medicine in the division of infectious diseases at the University of Alabama at Birmingham, said in a statement, “Many people living with HIV face challenges with daily therapies and are interested in alternative dosing options.“In clinical trials, approximately nine out of every 10 trial participants preferred long-acting cabotegravir and rilpivirine dosed every two months compared to daily oral cabotegravir and rilpivirine.”Viiv Healthcare is predominantly owned by GlaxoSmithKline. Lynn Baxter, Head of North America at ViiV Healthcare, said in a statement announcing the approval, “Today’s approval is a remarkable achievement given where HIV treatment was just a decade ago.
19.02 / 15:37
19.02 / 06:09
19.02 / 05:55
19.02 / 03:47
19.02 / 03:47
19.02 / 02:13
19.02 / 02:09
19.02 / 02:09
19.02 / 02:07
19.02 / 01:49
19.02 / 01:31
19.02 / 00:35
18.02 / 23:45
18.02 / 23:03
18.02 / 22:31
18.02 / 22:02
18.02 / 21:37
18.02 / 21:05
18.02 / 21:05
18.02 / 20:51
18.02 / 20:15
18.02 / 19:51
18.02 / 19:13
18.02 / 18:59
18.02 / 18:39
18.02 / 18:21
18.02 / 17:41
